Anil K Chandraker
Brigham and Women's Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anil K Chandraker as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:16 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT04608474 · Lipid Management in Renal Transplant Recipients Using Evolocumab.Brigham and Women's Hospital · completed · Hyperlipidemias · principal investigator
- N/ANCT02255123 · Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 StudyNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Cardiac Transplantation · study chair
- Ph2NCT01895127 · Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal TransplantationBrigham and Women's Hospital · terminated · Antibody-mediated Rejection, Humoral Rejection · principal investigator
- N/ANCT01442402 · APOL1 Gene Variants in African American Kidney Transplant RecipientsBrigham and Women's Hospital · terminated · Transplant;Failure,Kidney, Kidney Disease, Kidney Failure, Chronic · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:16 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Novel Therapies to Improve Renal and Cardiac Allograft OutcomesU01AI063623 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2013 · $2,543,579 awarded in 2013Same name and institution; not confirmed by an ID
- B-CELL DEPLETION BY ANTI-CD20 (RITUXIMAB)M01RR002635 · NCRR · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2007 to 2008 · $1,003 awarded in 2008Same name and institution; not confirmed by an ID
- The CD40-CD154 pathway in chronic allograft rejectionK08AI051664 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2001 to 2005 · $128,520 awarded in 2005Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:16 UTC. The ranking covers the 200 most relevant of 2 PubMed records, and a shared surname and initials can bring in a namesake. All 2 on PubMed
- Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma.J Clin Oncol · 202475 citationsRCR 10.9
- 54 citationsRCR 2.6